Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma-Reference-Cited by-同舟云学术

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Published:2004-04-01 Issue:4 Volume:53 Page:329-336
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:
Short-container-title:Cancer Chemotherapy and Pharmacology

Author:

Zamboni William C.,Gervais Anne C.,Egorin Merrill J.,Schellens Jan H. M.,Zuhowski Elleanor G.,Pluim Dick,Joseph Erin,Hamburger Deborah R.,Working Peter K.,Colbern Gail,Tonda Margaret E.,Potter Douglas M.,Eiseman Julie L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-003-0719-4.pdf

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomal Formulations of Metallodrugs for Cancer Therapy;International Journal of Molecular Sciences;2024-08-28

2. HER2-targeted, enzyme-activated liposomes show superior in vivo efficacy in an ovarian cancer model;Journal of Controlled Release;2024-07

3. Conventional vs PEGylated loaded liposomal formulations by microfluidics for delivering hydrophilic chemotherapy;International Journal of Pharmaceutics;2024-04

4. Evaluation of anticancer effect of micelle-encapsulated doxorubicin using gamma-distributed delay model;Journal of Drug Delivery Science and Technology;2024-01

5. Photoactivated HPPH-Liposomal therapy for the treatment of HPV-Negative head and neck cancer;Oral Oncology;2023-09